These small molecules offer potentialadvantages, including expedited pharmacokinetics, cost-effectiveness,increased stability, and enhanced tissue and tumor penetration, facilitatingcomprehensive evaluation of PD-L1 expression within the heterogeneoustumor microenvironment. Here, CD274 is linked to neoplasm.